Aneira Pharma, Inc.
🇺🇸United States
Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic Alopecia
- First Posted Date
- 2023-05-18
- Last Posted Date
- 2023-05-18
- Lead Sponsor
- Aneira Pharma, Inc.
- Target Recruit Count
- 14
- Registration Number
- NCT05864885
Proof of Concept Study of Latanoprost/Minoxidil (ANR-001.1) Topical Formulation
Early Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-03-30
- Last Posted Date
- 2023-03-30
- Lead Sponsor
- Aneira Pharma, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT05790941
- Locations
- 🇺🇸
WellMax, Indian Wells, California, United States
© Copyright 2024. All Rights Reserved by MedPath